TapImmune to Present at Biotech Showcase™ 2018


As a result of a leg injury suffered over the holidays, TapImmune President & CEO Peter Hoang has been compelled to cancel his planned presentation at Biotech Showcase in San Francisco. While fixing his son’s ceiling vent, Mr. Hoang slipped and fell, resulting in a moderate tear of his calf muscle, an injury that has made him unable to travel this week. On the advice of his physicians, he will use the week of January 8 to recuperate but will plan to return to his travel duties the week of January 15.

JACKSONVILLE, Florida, January 3, 2018 / TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that its President and CEO, Peter Hoang, will present at Biotech Showcase™ 2018, held January 8-10, 2018, in San Francisco, California.

TapImmune Presentation Details:

Date: Tuesday, January 9, 2018

Time: 4:30 p.m. (Pacific Time)

Location: Hilton Hotel, Franciscan A Ballroom; San Francisco, CA[/vc_column_text][vc_empty_space height=”8px”][vc_column_text][pr-disclaimer]